MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Country |
 USA |
IPO year |
1997 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
115 M |
Market Cap[1] |
$ 1.2 B |
EBITDA (LTM) |
$ -72.3 M |
P/E (LTM) |
- |
P/S (LTM) |
21.04 |
EPS (LTM) |
-0.81 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.37 | -8.67 % | $ 350 M | Nasdaq Global Select Market |  Britain |
 |
Adagene
ADAG
|
$ 1.65 | 3.77 % | $ 92.9 M | Nasdaq Global Market |  China |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.4 | -3.41 % | $ 8.18 B | Nasdaq Capital Market |  Australia |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 66.18 | 0.38 % | $ 8.85 B | Nasdaq Global Select Market,SPB | USA |
 |
Biogen
BIIB
|
$ 179.22 | -3.45 % | $ 26.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
AstraZeneca PLC
AZN
|
$ 94.23 | 0.64 % | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
- | -9.72 % | $ 5.89 M | Nasdaq Capital Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Ascendis Pharma A/S
ASND
|
$ 214.43 | 2.72 % | $ 5 B | Nasdaq Global Select Market |  Danmark |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Bristol-Myers Squibb Company
BMY
|
$ 56.12 | 0.63 % | $ 114 B | NYSE,SPB | USA |
 |
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market |  Canada |
 |
Caladrius Biosciences
CLBS
|
- | -16.75 % | $ 25.8 M | Nasdaq Capital Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.88 | 0.52 % | $ 908 M | Nasdaq Capital Market |  Israel |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
BioNTech SE
BNTX
|
$ 106.68 | 4.4 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 4.11 | -2.61 % | $ 8.94 B | NYSE American | Israel |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Catalyst Biosciences
CBIO
|
$ 11.04 | 0.55 % | $ 727 M | Nasdaq Capital Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market | Israel |
 |
Coherus BioSciences
CHRS
|
$ 1.7 | 3.03 % | $ 160 M | Nasdaq Global Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 29.26 | -0.48 % | $ 1.42 B | Nasdaq Global Select Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 26.03 | 1.4 % | $ 1.68 M | Nasdaq Global Select Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 4.26 | -0.12 % | $ 116 M | Nasdaq Global Market | France |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Burford Capital Limited
BUR
|
$ 9.61 | -0.36 % | $ 1.55 B | NYSE | Britain |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.